AU2001260467A1 - Integrin-targeting vectors having enhanced transfection activity - Google Patents
Integrin-targeting vectors having enhanced transfection activityInfo
- Publication number
- AU2001260467A1 AU2001260467A1 AU2001260467A AU6046701A AU2001260467A1 AU 2001260467 A1 AU2001260467 A1 AU 2001260467A1 AU 2001260467 A AU2001260467 A AU 2001260467A AU 6046701 A AU6046701 A AU 6046701A AU 2001260467 A1 AU2001260467 A1 AU 2001260467A1
- Authority
- AU
- Australia
- Prior art keywords
- integrin
- targeting vectors
- transfection activity
- enhanced transfection
- enhanced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0013089A GB0013089D0 (en) | 2000-05-30 | 2000-05-30 | Improved methods of transfection |
GB0013090.6 | 2000-05-30 | ||
GB0013089.8 | 2000-05-30 | ||
GB0013090A GB0013090D0 (en) | 2000-05-30 | 2000-05-30 | Intergrin-targetting vectors having enhanced transfection activity |
US28741001P | 2001-05-01 | 2001-05-01 | |
US60/287,410 | 2001-05-01 | ||
PCT/GB2001/002394 WO2001092542A2 (en) | 2000-05-30 | 2001-05-30 | Integrin-targeting vectors having enhanced transfection activity |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001260467A1 true AU2001260467A1 (en) | 2001-12-11 |
Family
ID=27255741
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001260467A Abandoned AU2001260467A1 (en) | 2000-05-30 | 2001-05-30 | Integrin-targeting vectors having enhanced transfection activity |
AU2001258659A Abandoned AU2001258659A1 (en) | 2000-05-30 | 2001-05-30 | Improved methods of transfection |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001258659A Abandoned AU2001258659A1 (en) | 2000-05-30 | 2001-05-30 | Improved methods of transfection |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1285081A2 (en) |
JP (1) | JP2003534804A (en) |
AU (2) | AU2001260467A1 (en) |
CA (1) | CA2410419A1 (en) |
WO (2) | WO2001092543A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002097116A2 (en) * | 2001-05-30 | 2002-12-05 | The Scripps Research Institute | Delivery system for nucleic acids |
AR037756A1 (en) * | 2001-12-17 | 2004-12-01 | Bayer Corp | ANTIBODY INHIBITING THE ACTIVITY OF THE PRECURSOR CELL FACTOR AND ITS USE FOR THE TREATMENT OF ASTHMA. |
FR2860236B1 (en) * | 2003-09-25 | 2006-01-06 | Theraptosis | PEPTIDES HAVING PARTICULARLY ANTI-ANGIOGENIC ACTIVITY AND THERAPEUTIC APPLICATIONS THEREOF |
EP2252627B1 (en) | 2008-01-24 | 2017-04-19 | Esperance Pharmaceuticals | Lytic domain fusion constructs and methods of making and using same |
EP3468609A1 (en) * | 2016-06-09 | 2019-04-17 | CureVac AG | Cationic carriers for nucleic acid delivery |
WO2017212009A1 (en) | 2016-06-09 | 2017-12-14 | Curevac Ag | Hybrid carriers for nucleic acid cargo |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0494175A4 (en) * | 1989-09-27 | 1993-05-05 | Athena Neurosciences, Inc. | Compositions for cell adhesion inhibition and methods of use |
JPH07505283A (en) * | 1992-03-20 | 1995-06-15 | ベイラー・カレッジ・オブ・メディシン | DNA transporter system and method of use |
US5981478A (en) * | 1993-11-24 | 1999-11-09 | La Jolla Cancer Research Foundation | Integrin-binding peptides |
AUPM747694A0 (en) * | 1994-08-16 | 1994-09-08 | Commonwealth Scientific And Industrial Research Organisation | Delivery of nucleic acids and peptides |
US5846782A (en) * | 1995-11-28 | 1998-12-08 | Genvec, Inc. | Targeting adenovirus with use of constrained peptide motifs |
US6051429A (en) * | 1995-06-07 | 2000-04-18 | Life Technologies, Inc. | Peptide-enhanced cationic lipid transfections |
US6252045B1 (en) * | 1996-03-15 | 2001-06-26 | Yale University | Human occludin, its uses and enhancement of drug absorption using occludin inhibitors |
US6210707B1 (en) * | 1996-11-12 | 2001-04-03 | The Regents Of The University Of California | Methods of forming protein-linked lipidic microparticles, and compositions thereof |
GB9711115D0 (en) * | 1997-05-29 | 1997-07-23 | Inst Of Child Health | Integrin-targeting vectors having enhanced transfection activity |
US6376471B1 (en) * | 1997-10-10 | 2002-04-23 | Johns Hopkins University | Gene delivery compositions and methods |
EP1053342A2 (en) * | 1998-02-09 | 2000-11-22 | Genzyme Corporation | Nucleic acid delivery vehicles |
AU4089899A (en) * | 1998-05-20 | 1999-12-06 | University Of Tennessee Research Corporation, The | Stable envelope proteins for retroviral, viral and liposome vectors and use in gene and drug therapy |
AU4417000A (en) * | 1999-04-15 | 2000-11-02 | Glaxo Group Limited | Novel pharmaceutical composition suitable for gene therapy |
-
2001
- 2001-05-30 EP EP01931977A patent/EP1285081A2/en not_active Withdrawn
- 2001-05-30 JP JP2002500735A patent/JP2003534804A/en active Pending
- 2001-05-30 AU AU2001260467A patent/AU2001260467A1/en not_active Abandoned
- 2001-05-30 AU AU2001258659A patent/AU2001258659A1/en not_active Abandoned
- 2001-05-30 CA CA002410419A patent/CA2410419A1/en not_active Abandoned
- 2001-05-30 WO PCT/GB2001/002396 patent/WO2001092543A2/en not_active Application Discontinuation
- 2001-05-30 WO PCT/GB2001/002394 patent/WO2001092542A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2001092543A2 (en) | 2001-12-06 |
WO2001092542A3 (en) | 2003-05-30 |
CA2410419A1 (en) | 2001-12-06 |
WO2001092542A2 (en) | 2001-12-06 |
WO2001092543A3 (en) | 2002-09-12 |
JP2003534804A (en) | 2003-11-25 |
EP1285081A2 (en) | 2003-02-26 |
AU2001258659A1 (en) | 2001-12-11 |
WO2001092542A8 (en) | 2003-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001252135A1 (en) | Therapeutic agents | |
AU1203501A (en) | Enhanced herbicides | |
AU5248900A (en) | Quickly disintegrating solid preparations | |
AU2001294192A1 (en) | Solid preparations | |
AU2001260327A1 (en) | Chair | |
AU2002214284A1 (en) | Anti-helicobacterial agents | |
AU2678800A (en) | Modified calycins | |
AU1132601A (en) | Feature interactions | |
AU1557901A (en) | Chair | |
AU2001263850A1 (en) | Pyrimidine-sulfonamides having endothelin-antagonist activity | |
AU2451500A (en) | Therapeutic agents | |
AU2333001A (en) | Double selection vector | |
AU2001260467A1 (en) | Integrin-targeting vectors having enhanced transfection activity | |
AU2001273903A1 (en) | Therapeutic agents | |
AU2376200A (en) | Insulin-synthesis genes | |
AU4063299A (en) | Skin whitener | |
AU2001288102A1 (en) | Solid preparations | |
AU2001252200A1 (en) | Chair | |
AU5973600A (en) | Therapeutic agents | |
AU2001294823A1 (en) | Hydrolases | |
AU2001272427A1 (en) | Solid preparations | |
AU2001265001A1 (en) | Improved office furniture system | |
AU2001282521A1 (en) | OCT preparations | |
AU4672401A (en) | Vectors | |
AU2001289075A1 (en) | Enhanced transfection system |